On Jul. 6, 2020, Merck announced new analyses from the Phase 2b trial (NCT03272347) evaluating the safety and…
On Jul. 6, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) approved Rukobia (fostemsavir), a new type of…
On Jul. 2, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the US Food…
On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD…
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
On Jun. 8, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics had entered into an…
On May 26, 2020, the National Institutes of Health (NIH) announced a new study that provides an alternative…
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
On Apr. 29, 2020, Scripps researchers announced they had developed a method for examining the machinery of HIV…
On Apr. 27, 2020, a novel means to prevent HIV infection was developed at the University of Nebraska…
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
On Mar. 23, 2020, researchers from the University of Oxford announced they have launched a new clinical trial…
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
On Mar. 9, 2020, among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily,…
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
On Nov. 4, 2019, Chembio Diagnostics announced its SURE CHECK HIV Self-Test has received World Health Organization (WHO)…
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
On Oct, 26, 2016, a team of researchers at the University of Arizona and University of Cambridge in…
On Apr. 4, 2016, UNMC researchers, Tony Wilson, Ph.D., and Susan Swindells, M.B.B.S., working with a $2.2 million,…
On May 31, 2015, the New England Primate Research Center (NEPRC) announced that it intended to wind down…
On Sept. 3, 2014, Oregon Health & Science University (OHSU) announced it had been awarded a $25 million…
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…